EnPro price target raised to $90 from $64 at Sterne Agee Sterne Agee increased its price target on EnPro after a judge fined the company a lower than expected amount for mesothelioma claims. The firm expects the stock to transition from being viewed as a special situation to being regarded as a value story. It predicts that the shares will continue to rise, and it keeps a Buy rating on the stock.
News For NPO From The Last 14 Days
Check below for free stories on NPO the last two weeks.